Freag, May S.
Takeda Pharmaceuticals U.S.A., Inc.,
United States
2024 Rank: 281411
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2294 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 281411 | 323630 |
| Total Cites | 214 | 219 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 100 | 102 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 121 | 125 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 200 | 203 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
2.28%
|
|
Freag, May S.
Harvard Medical School,
United States
2023 Rank: 246796
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1969 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 246796 | 266611 |
| Total Cites | 211 | 220 |
| H-index | 9 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 94 | 97 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 129 | 135 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 193 | 198 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
4.09%
|
|
Freag, May S.
Harvard Medical School,
United States
2022 Rank: 327978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2761 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 327978 | 319147 |
| Total Cites | 208 | 224 |
| H-index | 9 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 75 | 84 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 119 | 130 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 196 | 202 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.11 |
| Self-Citation Percentage |
7.14%
|
|
Freag, May S.
Alexandria University,
Egypt
2020 Rank: 272981
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2039 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 272981 | 252699 |
| Total Cites | 179 | 217 |
| H-index | 8 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 71 | 88 |
| Number of Single+First+Last Authored Papers | 13 | 13 |
| Total Cites to Single+First+Last Authored Papers | 100 | 120 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 165 | 178 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.22 |
| Self-Citation Percentage |
17.51%
|
|